<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01549067</url>
  </required_header>
  <id_info>
    <org_study_id>Sprit</org_study_id>
    <nct_id>NCT01549067</nct_id>
  </id_info>
  <brief_title>The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey</brief_title>
  <acronym>Sprit</acronym>
  <official_title>The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Medical Doctor Association</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese Medical Doctor Association</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Collect the real clinical background of advanced colorectal cancer c of China.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Primary Objectives of this study is collect the real clinical background of advanced
      colorectal cancer treatment situation of China. The Secondary Objectives is the mutation of
      K-ras , targeting therapy , use present situation of cetuximab and liver metastases treatment
      situation of colorectal cancer patients.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">3700</enrollment>
  <condition>Advanced Malignant Neoplasm</condition>
  <condition>Colorectal Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Advanced Colorectal Cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with histologically or cytologically confirmed diagnosis of metastatic
             colorectal cancer.

        Exclusion Criteria:

          -  Patients with histologically or cytologically confirmed diagnosis other than
             metastatic colorectal cancer.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lin Shen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Cancer Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ruihua Xu, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lin Shen, MD</last_name>
    <phone>010-88140650</phone>
    <email>lin100@medmail.com.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rui-hua Xu, MD , PhD</last_name>
    <phone>020-87343468</phone>
    <email>xurh@sysucc.org.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking University Cancer Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lin Shen, MD</last_name>
      <phone>010-88140650</phone>
      <email>lin100@medmail.com.cn</email>
    </contact>
    <investigator>
      <last_name>Lin Shen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sun Yat-sen University Cancer Center</name>
      <address>
        <city>Zhongshan</city>
        <state>Guangzhou</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rui-hua Xu, MD , PhD</last_name>
      <phone>020-87343468</phone>
      <email>xurh@sysucc.org.cn</email>
    </contact>
    <investigator>
      <last_name>Rui-hua Xu, MD , PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2012</study_first_submitted>
  <study_first_submitted_qc>March 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2012</study_first_posted>
  <last_update_submitted>March 13, 2012</last_update_submitted>
  <last_update_submitted_qc>March 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 14, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Medical Doctor Association</investigator_affiliation>
    <investigator_full_name>Lin Shen，MD &amp; Ruihua Xu，MD、PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Advanced</keyword>
  <keyword>Colorectal Cancer</keyword>
  <keyword>Targeted chemotherapy</keyword>
  <keyword>Surgery</keyword>
  <keyword>Radiotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

